|
Press Releases |
|
 |
|
Thursday, August 28, 2025 |
|
Hua Medicine Announces 2025 Interim Results |
Hua Medicine (the 'Company', HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2025 (the 'Reporting Period'), as well as the Company's business progress during the first half of the year and future outlook. During the Reporting Period, the commercialization of the Company's core product, HuaTangNing'(dorzagliatin tablets), accelerated. The Company's independent operational capabilities improved significantly. more info >> |
|
Monday, June 23, 2025 |
|
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis |
Hua Medicine ("the Company", stock code: 2552.HK) announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA). more info >> |
|
Friday, March 28, 2025 |
|
Hua Medicine Announces 2024 Annual Results |
Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook. more info >> |
|
Tuesday, March 18, 2025 |
|
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce |
On March 17th, the highly anticipated 7th Commendation and Exchange Conference for the Leading Figures in Shanghai's Industry and Commerce was brought to a successful conclusion. Dr. Li Chen, the founder and CEO of Hua Medicine, was awarded the title of "A Leading Figure in Shanghai's Industry and Commerce" for his outstanding contributions and innovative leadership in the field of biomedicine. more info >> |
|
Monday, March 3, 2025 |
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters |
On February 27th, the awarding ceremony of the second batch of Shanghai Innovative Enterprise Headquarters was held in Shanghai. Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee and Mayor of Shanghai, awarded the certificates to 49 innovative enterprise headquarters, and Hua Medicine was among them. more info >> |
|
Saturday, November 30, 2024 |
|
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate |
Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China BioMed Innovation and Investment Conference (CBIIC). more info >> |
|
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC |
Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC). more info >> |
|
Friday, October 25, 2024 |
|
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' |
The 17th C.C. Tan Life Science Award ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the C.C. Tan Life Science Industrialization Award . more info >> |
|
Friday, August 30, 2024 |
|
Hua Medicine Announces 2024 Interim Results |
Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company's business progress for the first half of the year and business outlook. more info >> |
|
Friday, August 25, 2023 |
|
Hua Medicine Announces 2023 Interim Results |
First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Counterfeit Products Sold Online in Malaysia Threaten Halal Compliance, Consumer Health, and the E-Commerce Sector, Says Muslim Consumers Association (PPIM)
Sept 18, 2025 13:20 HKT/SGT
|
|
|
Dongwu Cement (00695.HK) Undergoes Major Transformation with Suzhou State Capital Takeover
Sept 18, 2025 08:30 HKT/SGT
|
|
|
GMG Launches First to Market Multi Language Global Graphene Enhanced Product Range for Distributors
Sept 17, 2025 19:39 HKT/SGT
|
|
|
Casa Minerals Inc Announces Advanced Ground IP Survey at the Arsenault Project
Sept 17, 2025 18:09 HKT/SGT
|
|
|
Definitive agreement to implement a joint mine plan between Los Bronces and Andina copper mines
Sept 17, 2025 18:57 JST
|
|
|
Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches 'Global Open Innovation' for U.S. Startups
Sept 17, 2025 17:30 HKT/SGT
|
|
|
Anti-MTBR (microtubule binding region) Tau Antibody Etalanetug Granted FDA Fast Track Designation
Sept 17, 2025 18:20 JST
|
|
|
HKTDC welcomes 2025 Policy Address
Sept 17, 2025 17:01 HKT/SGT
|
|
|
Honda Announces New Electric Motorcycle "Honda WN7" in Europe
Sept 17, 2025 17:46 JST
|
|
|
Ultraman Card Game Original Illustration of "Alien Metron" By Manga Artist Yukinobu Tatsu to be Included in the Upcoming Booster Pack Release
Sept 17, 2025 12:56 HKT/SGT
|
|
|
Professor Lin Xiang Xiong Hosts Landmark Art Exhibition and Peace Prize Ceremony in Paris
Sept 17, 2025 11:44 HKT/SGT
|
|
|
How Not to Lose the Billion Dollars You Didn't Know You Had-Groundbreaking Guide to Protecting Family Fortunes
Sept 17, 2025 10:00 HKT/SGT
|
|
|
Karbon-X Corp. Files Year-End Financial Results
Sept 17, 2025 09:08 HKT/SGT
|
|
|
TruMerit Adds Two More Global Credentials for Rehabilitation Care Workers
Sept 17, 2025 08:00 HKT/SGT
|
|
|
EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
Sept 17, 2025 9:00 JST
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|